Product Selection Process
How do products get on the formulary?
Any new product needs to be licensed by Health Canada before it will be considered for the national formulary. New products can be added to the formulary in one of two ways, either through Canadian Blood Services’ RFP process or through a product review process involving Canadian Blood Services and the Canadian Agency for Drugs and Technologies in Health (CADTH) and must be approved by the provincial and territorial ministries of health (excluding Quebec).
*The product selection process for the national plasma protein and related products formulary is under review. Please contact PPRPFormularyprogram@blood.ca for any questions.